Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04865666
Other study ID # H19-01915
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 25, 2019
Est. completion date February 14, 2020

Study information

Verified date April 2021
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this 8-week pilot pragmatic randomized controlled trial was to examine the real-world impact of movr on functional movement, flexibility, strength, and cardiovascular fitness.


Description:

Thousands of mobile apps available for download are geared towards health and fitness, yet limited research has evaluated the real-world effectiveness of such apps. The movr app is an mHealth app designed to enhance physical functioning by prescribing functional movement training based on individualized movement assessments. movr's influence on functional movement and physical fitness (flexibility, strength, and cardiovascular fitness) has not yet been established empirically. Thus, the objective of this 8-week pilot pragmatic randomized controlled trial was to examine the real-world impact of movr on functional movement, flexibility, strength, and cardiovascular fitness.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date February 14, 2020
Est. primary completion date February 14, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Ages 18 to 50 years - Ability to read and write English - Owned a mobile device that could download applications from the App Store or Google Play Exclusion Criteria: - Previously used the movr app - Had any contraindications to exercise based on the Get Active Questionnaire

Study Design


Related Conditions & MeSH terms


Intervention

Device:
movr mHealth App
The exercises prescribed through the movr app were accompanied with videos, images, and detailed instructions on how to complete them. These exercises consisted of basic movement and mobility patterns and are designed to promote functional movement. Participants were instructed to complete a total of four 'Minis' and two workout 'Builder' sessions per week. Workout Builders are designed to be longer exercise sessions tailored to the user's desired exercise time (15, 30, 45 or 60 min), equipment available (TRX Band, kettlebell, chin-up bar, dumbbells, foam roller, or none), target body region (lower, upper, or whole body), and specific exercise goal ('get sweaty,' 'build strength,' or 'develop mobility'). Version 3.6 of the movr app was used at the start of data collection and was updated to Version 4.1 over the course of the trial. No significant changes were made to the app or to the exercise prescription functionality throughout those updates.

Locations

Country Name City State
Canada Diabetes Prevention Research Group Laboratory Kelowna British Columbia

Sponsors (3)

Lead Sponsor Collaborator
University of British Columbia Lululemon Athletica, Mitacs

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes from baseline in moderate-to-vigorous physical activity at 8-week follow-up Participants' physical activity levels were measured using the International Physical Activity Questionnaire - Short Form (IPAQ-SF) Baseline and 8-week follow-up
Other Anthropometric measures completed at baseline and 8-week follow-up Participants' height and body mass was assessed using a stadiometer Baseline and 8-week follow-up
Other Changes from baseline in movr Movement Assessment scores at 4- and 8-week follow-up Participants were instructed to complete the 10 self-reported Movement Assessment tests through their individual movr app account. These movement tests are performed to assess mobility, motor control, and strength, and are used to determine deficiencies in movement patterns and to provide prescriptive information for exercise selection within the app. Participants were prompted (via email) to complete their Movement Assessments again at 4 and 8 weeks Baseline, and 4- and 8-week follow-up
Other movr app usage data measured across 8-week study period and over 8-12-week voluntary follow-up The number of Minis and Builder sessions completed per week were recorded on the movr database server over the 8 week study period and additional voluntary use from 8-12 weeks Across 8 week study period and over 8-12 week voluntary app usage period
Other movr app usability and acceptability measured at 8-week follow-up At the Visit 2 follow-up testing, participants were asked to respond to a series of Likert-type scale questions corresponding to the usability and acceptability of the movr app over the 8-week intervention period. In addition, questions included in the semi-structured interviews were also used to evaluate the usability and acceptability of the movr app 8-week follow-up
Primary Change from baseline in functional movement screen (FMS) at 8-week follow-up The 100-point version of the functional movement screen (FMS) was used to identify individual movement patterns. The FMS is a screening tool to assess full body movement patterns and consists of seven core movement tests (deep squat, hurdle step, in-line lunge, active straight-leg raise, shoulder flexibility, trunk stability push-up, and quadruped rotary stability). The seven FMS movement screens were performed by each participant and recorded using a portable observation lab (Noldus) with two video cameras (one shot on a sagittal plane [side] view and the other from a frontal plane [front/back] view). The standardized FMS verbal instructions were provided by the researcher. The video-based testing was completed to minimize participant burden during lab visits and to blind participants to their FMS scores for each of the movements. Scoring of the FMS was completed at a later time using the video recordings. Baseline and 8-week follow-up
Secondary Change from baseline in flexibility at 8-week follow-up The shoulder reach flexibility test was used to assess upper body flexibility and the sit and reach, active straight-leg raise (ASLR), and the half-kneeling dorsiflexion tests were used to assess lower body flexibility. For the shoulder reach test, a soft tape measure was used to measure the distance between participants' closed fists, and for the ASLR, range of motion in degrees were measured on each leg using a digital inclinometer (Metriks, Canada). For each of the flexibility tests (excluding sit and reach), scores from the left and right side (arm or leg) were summed and total scores are reported. A lower measurement score on the shoulder flexibility test indicates greater flexibility, while higher scores on the sit and reach, ASLR, and half-kneeling dorsiflexion tests indicate greater flexibility. Baseline and 8-week follow-up
Secondary Change from baseline in muscular endurance at 8-week follow-up A push-up test was used to determine the maximal number of successive push-up repetitions that participants could complete until failure. The test protocols followed the Canadian Society for Exercise Physiology (CSEP) recommendations, including use of a modified push-up protocol for all women in the study. Baseline and 8-week follow-up
Secondary Change from baseline in handgrip strength at 8-week follow-up Handgrip strength was assessed using a maximal voluntary contraction of an isometric handgrip squeeze using a Smedley spring handgrip dynamometer (BASELINE®). Scores from the left and right hand were summed and total scores are reported. Baseline and 8-week follow-up
Secondary Change from baseline in lower body power at 8-week follow-up A countermovement jump (CMJ) was conducted using the My Jump 2 mobile app on an iPhone 8 to assess lower body power. The validity and reliability of the My Jump 2 has been established previously. Baseline and 8-week follow-up
Secondary Change from baseline in cardiovascular fitness at 8-week follow-up Participants performed an incremental maximal oxygen uptake (V?O2max) test on a cycle ergometer (Lode Excalibur Sport). The resistance on the cycle ergometer was automatically increased (1W every 3 s for women, 1W every 2 s for men) until participants reached volitional exhaustion or could no longer maintain a pedal cadence of at least 50 rpm. A metabolic cart with an online gas collection system (Parvo Medics, TrueOne 2400) was used to collect expired gas samples continuously and V?O2max was calculated using the mean of the highest average oxygen consumption over a 30-s period (in mL·kg-1·min-1). Baseline and 8-week follow-up
Secondary Changes from baseline in health locus of control at 8-week follow-up Form B of the Multidimensional Health Locus of Control Scale was used to measure health locus of control Baseline and 8-week follow-up
Secondary Changes from baseline in perceptions of health at 8-week follow-up The Short Form (36) Health Survey was used to assess perceptions of health status Baseline and 8-week follow-up
Secondary Changes from baseline in physical activity enjoyment at 8-week follow-up Enjoyment of physical activity completed over the past week was measured pre- and post-intervention using the Physical Activity Enjoyment Scale (PACES). This scale has 18 items that participants rated on a 7-point bipolar scale (from 1 to 7). Baseline and 8-week follow-up
Secondary Changes from baseline in well-being, enjoyment, satisfaction with physical functioning at 1, 2, 3, 4, 5, 6, 7, and 8-week follow-up The Subjective Exercise Experiences Scale (SEES) was used to measure participants' positive well-being, psychological distress and fatigue. The single-item Exercise Enjoyment Scale (EES) was used to measure exercise enjoyment. A 5-item measure of satisfaction with physical functioning was used assess participants' satisfaction with their (1) overall physical functioning, (2) cardiovascular fitness, (3) muscle strength, (4) flexibility, and (5) balance. This set of questions was administered at the end of each week throughout the 8-week intervention period as well as pre- and post-intervention in the form of an email that included a Qualtrics link to the survey Baseline and 1, 2, 3, 4, 5, 6, 7, and 8-week follow-up
Secondary Semi-structured interviews completed at baseline and 8-week follow-up At the very beginning of Visit 1 and at the end of Visit 2, a random sub-sample of 15 participants from the movr group participated in semi-structured interviews that were recorded using an audio recording device (Sony ICD PX333 Digital Voice Recorder). Interview questions addressed general beliefs about fitness mobile apps and perceptions of fitness and physical functioning, individual experiences with using the movr app, how exercise perceptions may change from before to after using the movr app, and how to optimize future design and delivery of the movr app Baseline and 8-week follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1